GILD — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates GILD as Neutral with 50% confidence in the Healthcare sector.
AI Analysis Summary
Synthesizer unavailable. Based on investor framework average (50/100): AS-Rank 3 (neutral) signal
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 35/100
- Bill Ackman (Activist Investing): Grade C — 59/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Hold
Price Intelligence
- Current price: $130.40
- Price target: $151.32 (+16%)
- Risk level: medium
- Horizon: medium term
Quality Assessment
- Balance sheet: adequate
- Cash flow: fair
- Competitive moat: intangible assets
Peer Group Analysis
GILD is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.